Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lenz

Showing results (91-100 of 294) with videos related to

Pageof 30
Sort By:
British Journal of Haematology|June 26, 2026
Response-adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohortFarina Eigendorff, Fabian Görke, Vanja Zeremski, et al.
Annals of Hematology|July 10, 2023
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)Alexander Pohlmann, Eva Bentgens, Christoph Schülke, et al.
Frontiers in Oncology|June 15, 2026
Health-related quality of life after autologous stem cell transplantation for multiple myeloma or lymphoma impacts professional activity- an analysis from two German tertiary care centersAnna Franziska Hamm, Ajelet Loesche, Christine Eisfeld, et al.
European Journal of Haematology|July 12, 2018
<sup>90</sup> Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experienceEva U Spukti, Lars Henning Schmidt, Arik Schulze, et al.
Leukemia & Lymphoma|September 5, 2017
Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCLMareike Frick, Marcus Bettstetter, Simone Bertz, et al.
Cancer Research|August 5, 2016
Splenic Marginal Zone Granulocytes Acquire an Accentuated Neutrophil B-Cell Helper Phenotype in Chronic Lymphocytic LeukemiaMarcel Gätjen, Franziska Brand, Michael Grau, et al.
Cancer Research and Treatment|July 27, 2016
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic LeukemiaMathias Lutz, Arik B Schulze, Elisabeth Rebber, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2026
Survival Outcomes After Front-Line Consolidation With High-Dose Melphalan and Autologous Stem Cell Transplantation in Younger and Elderly Multiple Myeloma Patients: A Retrospective Bi-Centric AnalysisArne Strotmann, Theo Leitner, Paolo Mazzeo, et al.
Cancer Medicine|May 21, 2024
Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in EuropeEnver Aydilek, Gerald Wulf, Friedrich Schwarz, et al.
Bone Marrow Transplantation|May 3, 2024
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patientsPhilipp Berning, Lina Kolloch, Christian Reicherts, et al.
Pageof 30

Showing results (91-100 of 294) with videos related to

Sort By:
Pageof 30
British Journal of Haematology|June 26, 2026
Response-adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohortFarina Eigendorff, Fabian Görke, Vanja Zeremski, et al.
Annals of Hematology|July 10, 2023
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)Alexander Pohlmann, Eva Bentgens, Christoph Schülke, et al.
Frontiers in Oncology|June 15, 2026
Health-related quality of life after autologous stem cell transplantation for multiple myeloma or lymphoma impacts professional activity- an analysis from two German tertiary care centersAnna Franziska Hamm, Ajelet Loesche, Christine Eisfeld, et al.
European Journal of Haematology|July 12, 2018
<sup>90</sup> Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experienceEva U Spukti, Lars Henning Schmidt, Arik Schulze, et al.
Leukemia & Lymphoma|September 5, 2017
Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCLMareike Frick, Marcus Bettstetter, Simone Bertz, et al.
Cancer Research|August 5, 2016
Splenic Marginal Zone Granulocytes Acquire an Accentuated Neutrophil B-Cell Helper Phenotype in Chronic Lymphocytic LeukemiaMarcel Gätjen, Franziska Brand, Michael Grau, et al.
Cancer Research and Treatment|July 27, 2016
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic LeukemiaMathias Lutz, Arik B Schulze, Elisabeth Rebber, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2026
Survival Outcomes After Front-Line Consolidation With High-Dose Melphalan and Autologous Stem Cell Transplantation in Younger and Elderly Multiple Myeloma Patients: A Retrospective Bi-Centric AnalysisArne Strotmann, Theo Leitner, Paolo Mazzeo, et al.
Cancer Medicine|May 21, 2024
Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in EuropeEnver Aydilek, Gerald Wulf, Friedrich Schwarz, et al.
Bone Marrow Transplantation|May 3, 2024
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patientsPhilipp Berning, Lina Kolloch, Christian Reicherts, et al.
Pageof 30